EDGAR Filing Documents for 0001193125-11-219518

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-11-219518

Filing Date

2011-08-11

Accepted

2011-08-11 15:32:54

Documents

Period of Report

2011-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d10q.htm	10-Q	516675
2	CERTIFICATION OF EXECUTIVE CHAIRMAN OF THE BOARD	dex311.htm	EX-31.1	6116
3	CERTIFICATION OF CHIEF FINANCIAL OFFICER	dex312.htm	EX-31.2	6110
4	CERTIFICATION OF EXECUTIVE CHAIRMAN OF THE BOARD	dex321.htm	EX-32.1	2902
5	CERTIFICATION OF CHIEF FINANCIAL OFFICER	dex3211.htm	EX-32.1	2894
	Complete submission text file	0001193125-11-219518.txt		2214016

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	pcrx-20110630.xml	EX-101.INS	278354
7	XBRL TAXONOMY EXTENSION SCHEMA	pcrx-20110630.xsd	EX-101.SCH	14137
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	pcrx-20110630_cal.xml	EX-101.CAL	36598
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	pcrx-20110630_def.xml	EX-101.DEF	14754
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	pcrx-20110630_lab.xml	EX-101.LAB	149683
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	pcrx-20110630_pre.xml	EX-101.PRE	94885

Mailing Address 5 SYLVAN WAY SUITE 125 PARSIPPANY NJ 07054

Business Address 5 SYLVAN WAY SUITE 125 PARSIPPANY NJ 07054 973-254-3560

Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)